• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA IM VITAMIN B12 (VB12); RADIOASSAY, VITAMIN B12

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA IM VITAMIN B12 (VB12); RADIOASSAY, VITAMIN B12 Back to Search Results
Model Number N/A
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/11/2023
Event Type  malfunction  
Event Description
A falsely elevated vitamin b12 (vb12) result was obtained on a patient sample on an atellica im 1600 instrument.The erroneous result was not reported to the physician(s).The sample was repeated on two alternate atellica im instruments.The repeat results were lower than the erroneous result.The repeat results were reported, as the correct result, to the physician(s).There are no known reports of patient intervention or adverse health consequences due to the falsely elevated vitamin b12 (vb12) result.
 
Manufacturer Narrative
An outside united states (ous) customer contacted a siemens customer care center to report a falsely elevated vitamin b12 (vb12) result that was obtained on a patient sample on an atellica im 1600 instrument.The erroneous result was not reported to the physician(s).The sample was repeated on two alternate atellica im instruments.The repeat results were lower than the erroneous result.The repeat results were reported, as the correct result, to the physician(s).Calibration was valid on the day of the event.Quality control (qc) levels two and three recovered within ranges, and qc level one failed on the day of the event.The interpretation of results section of the atellica im vitamin b12 (vb12) instructions for use (ifu) states "results of this assay should always be interpreted in conjunction with the patient's medical history, clinical presentation, and other findings." siemens is investigating.
 
Manufacturer Narrative
Siemens filed the initial mdr 1219913-2023-00151 on 02-august-2023.Additional information 23-august-2023: siemens has investigated the customer report for discordant patient results for one patient sample with vitamin b12 (vb12) lot 286 on atellica im 1600 instrument (ih00340).Patient vb12 results were initially tested on ih00340 and then retested on alternate atellica im modules.The patient sample in question demonstrated a decrease in results when retested at a later time same day.No additional logs or quality control (qc) data were able to be reviewed due to the late date of escalation and logs being purged from instrument.No other patient samples were affected at this time of this isolated divergent result.Siemens cannot rule out preanalytical handling of the patient sample as the cause of the discordant patient result at customer site.The quality of the specimen could potentially impact the performance of the atellica im vb12 assays.Cellular debris could potentially be responsible for the higher-than-expected vb12 results.When samples are centrifuged prior to testing and remain upright or allowed to settle for an extended period, the vb12 assay can be impacted resulting in lower values.Siemens recommends following all collection tube handling instructions provided by the manufacturer.Siemens was unable to confirm if the customer is operational or if additional assistance was needed as no response was received upon multiple attempts to request for update.The atellica im vitamin b12 (vb12) lot 286 is performing as intended.A product performance issue has not been identified.No further evaluation of the device is required.In section h6, the investigation findings and investigation conclusions codes were updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATELLICA IM VITAMIN B12 (VB12)
Type of Device
RADIOASSAY, VITAMIN B12
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict ave
tarrytown NY 10591
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
333 coney street
east walpole MA 02032
Manufacturer Contact
karen confort
333 coney st.
east walpole, MA 02032
3392069063
MDR Report Key17443803
MDR Text Key320235342
Report Number1219913-2023-00151
Device Sequence Number1
Product Code CDD
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
K993571
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 08/29/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/05/2023
Device Model NumberN/A
Device Catalogue Number10995715
Device Lot Number286
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/26/2023
Initial Date FDA Received08/02/2023
Supplement Dates Manufacturer Received08/23/2023
Supplement Dates FDA Received08/29/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/05/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age2 YR
Patient SexFemale
-
-